Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98,685,316
-
Total 13F shares
-
145,985,292
-
Share change
-
-8,200,854
-
Total reported value
-
$2,821,832,723
-
Put/Call ratio
-
109%
-
Price per share
-
$19.33
-
Number of holders
-
158
-
Value change
-
-$467,032,693
-
Number of buys
-
80
-
Number of sells
-
116
Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q1 2022
As of 31 Mar 2022,
GoodRx Holdings, Inc. - Common Stock (GDRX) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
145,985,292 shares.
The largest 10 holders included
Francisco Partners Management, LP, MORGAN STANLEY, VANGUARD GROUP INC, LIGHT STREET CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, Silver Lake Group, L.L.C., Technology Crossover Management X, Ltd., DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP, Dragoneer Investment Group, LLC, and Rip Road Capital Partners LP.
This page lists
158
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.